ライフサイエンスコーパス: immunosorbent

1 describe an electronics-based Enzyme-Linked ImmunoSorbent Assay (eELISA), using a Lab-on-a-Printed C

2 roconversion as assessed by an enzyme-linked immunosorbent assay (ELISA) against the glycoprotein of

3 -coated microarray assay, (ii) enzyme-linked immunosorbent assay (ELISA) and (iii) in-vivo co-express

4 Through an enzyme-linked immunosorbent assay (ELISA) and a histo-blood group anti

5 ekly by use of a commercial GM enzyme-linked immunosorbent assay (ELISA) and a PCR assay based on amp

6 and assessed the responses by enzyme-linked immunosorbent assay (ELISA) and competition assays.

7 patica-specific serum antibody enzyme-linked immunosorbent assay (ELISA) and fluke egg counts.

8 nsiderably wider than those of enzyme-linked immunosorbent assay (ELISA) and other immunoassay method

9 duced recombinant Pfs25 as the enzyme-linked immunosorbent assay (ELISA) antigen.

10 Immunoassays such as the enzyme-linked immunosorbent assay (ELISA) are commonly used to quantif

11 ve immunoassay formats such as enzyme-linked immunosorbent assay (ELISA) are the specificity, speed,

12 bodies to AT1R and ETAR by the enzyme-linked immunosorbent assay (ELISA) assay.

13 immunoassay based on specific enzyme linked immunosorbent assay (ELISA) combined with the PEC method

14 lts with those obtained by the enzyme-linked immunosorbent assay (ELISA) conventional method (p-value

15 Enzyme-linked immunosorbent assay (ELISA) demonstrates markedly increa

16 anti-HEV antigen (Ag)-specific enzyme-linked immunosorbent assay (ELISA) directed against the HEV cap

17 -gamma release was measured by enzyme-linked immunosorbent assay (ELISA) following overnight stimulat

18 Fab/scFv in the context of an enzyme-linked immunosorbent assay (ELISA) for HBeAg quantification, wh

19 developed a sensitive sandwich enzyme-linked immunosorbent assay (ELISA) for PEG by tethering an anti

20 pecific and sensitive sandwich enzyme-linked immunosorbent assay (ELISA) for the detection and quanti

21 A sensitive, competitive enzyme-linked immunosorbent assay (ELISA) for the detection of the ant

22 ghput, objective peptide-based enzyme-linked immunosorbent assay (ELISA) for use alone or in combinat

23 Using a novel enzyme-linked immunosorbent assay (ELISA) format as a screening assay,

24 eas those for the Ortho HCV Ag enzyme-linked immunosorbent assay (ELISA) had the lowest quality.

25 The enzyme-linked immunosorbent assay (ELISA) has been proposed as an alte

26 of CYFRA-21-1 obtained through enzyme linked immunosorbent assay (ELISA) in saliva samples of oral ca

27 R, showed the best response in enzyme-linked immunosorbent assay (ELISA) in terms of sensitivity and

28 Enzyme-linked immunosorbent assay (ELISA) is a valuable technique to d

29 Enzyme-linked immunosorbent assay (ELISA) is one of the most important

30 Enzyme linked immunosorbent assay (ELISA) is one of the most widely us

31 Enzyme-linked immunosorbent assay (ELISA) measurements of the supernat

32 OWLS immunosenor with HPLC and enzyme-linked immunosorbent assay (ELISA) methods for the detection of

33 ion methods such as culturing, enzyme linked immunosorbent assay (ELISA) or polymerase chain reaction

34 Enzyme-linked immunosorbent assay (ELISA) performed on supernatant flu

35 An enzyme-linked immunosorbent assay (ELISA) quantified clothianidin in l

36 BA, and immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) results were compared and as

37 in fractions using competitive enzyme linked immunosorbent assay (ELISA) technique and found that the

38 or chip was validated using an enzyme-linked immunosorbent assay (ELISA) technique with a regression

39 We developed an enzyme-linked immunosorbent assay (ELISA) to measure the various activ

40 roteomics approach followed by enzyme-linked immunosorbent assay (ELISA) validation.

41 al dengue NS1 capture using an enzyme-linked immunosorbent assay (ELISA) was applied to our results.

42 dy, a paper-based microfluidic enzyme-linked immunosorbent assay (ELISA) was developed as a screening

43 A quantitative Enzyme-Linked ImmunoSorbent Assay (ELISA) was formatted to assess rela

44 ssful detection with the rapid enzyme-linked immunosorbent assay (ELISA) was more variable and depend

45 ia trachomatis elementary body enzyme-linked immunosorbent assay (ELISA) was used to investigate seru

46 The computationally designed enzyme-linked immunosorbent assay (ELISA) was validated using 169 fiel

47 in 5 tests only: polyspecific enzyme-linked immunosorbent assay (ELISA) with intermediate threshold

48 e came close to a conventional enzyme-linked immunosorbent assay (ELISA) without the need for an enzy

49 k increased cBIN1 detection by enzyme-linked immunosorbent assay (ELISA), and cBIN1 level decreased i

50 eactivity to E-pore peptide by enzyme-linked immunosorbent assay (ELISA), and histology was performed

51 methods such as neuroimaging, enzyme-linked immunosorbent assay (ELISA), and polymerase chain reacti

52 ometry, cytokines by multiplex enzyme-linked immunosorbent assay (ELISA), and the microbiota by 16S r

53 tier test is a low-specificity enzyme-linked immunosorbent assay (ELISA), and the second-tier tests a

54 ysis, quantitative PCR (qPCR), enzyme-linked immunosorbent assay (ELISA), and Western blot assay.

55 centralized laboratories using Enzyme-Linked ImmunoSorbent Assay (ELISA), faster on-site diagnosis wo

56 Enzyme-linked immunosorbent assay (ELISA), flow cytometry, and Western

57 al-aptasensor and conventional enzyme-linked immunosorbent assay (ELISA), operated with time consumin

58 ared to a clinically validated enzyme-linked immunosorbent assay (ELISA), resulting in excellent Pear

59 Using enzyme-linked immunosorbent assay (ELISA), we obtain seropositivity of

60 An enzyme-linked immunosorbent assay (ELISA)-like method based on the MIP

61 ntibody was confirmed using an enzyme-linked immunosorbent assay (ELISA)-type binding assay.

62 for NE using a single-analyte enzyme-linked immunosorbent assay (ELISA).

63 on assay (CCNA) and tgcBIOMICS enzyme-linked immunosorbent assay (ELISA).

64 ound time compared to standard enzyme-linked immunosorbent assay (ELISA).

65 binant protein (rVP1) indirect enzyme-linked immunosorbent assay (ELISA).

66 rum via a miniature bead-based enzyme-linked immunosorbent assay (ELISA).

67 pecific antibodies by indirect enzyme-linked immunosorbent assay (ELISA).

68 by other spectral methods and enzyme linked immunosorbent assay (ELISA).

69 esults have been validated via enzyme linked immunosorbent assay (ELISA).

70 that can be used to conduct an enzyme-linked immunosorbent assay (ELISA).

71 n of dengue enveloped virus in enzyme-linked immunosorbent assay (ELISA).

72 ow cytometry, and cytokines by enzyme-linked immunosorbent assay (ELISA).

73 for an automated and one-step enzyme-linked immunosorbent assay (ELISA).

74 to all viruses as measured by enzyme-linked immunosorbent assay (ELISA).

75 y is as good as or better than enzyme-linked immunosorbent assay (ELISA).

76 ative PCR, immunoblotting, and enzyme-linked immunosorbent assay (ELISA).

77 c fever detection has been the enzyme-linked immunosorbent assay (ELISA); however, newer technologies

78 e responses using glycoprotein enzyme-linked immunosorbent assay (gpELISA) and interferon-gamma enzym

79 anti-ZIKV IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) followed by supplemental

80 using an IgM antibody capture enzyme-linked immunosorbent assay (MAC-ELISA) for screening, followed

81 -specific IgM antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA).

82 ss spectrometry method than by enzyme-linked immunosorbent assay (mean difference of SD of residuals:

83 chnology, we introduce the nanoswitch-linked immunosorbent assay (NLISA), a detection platform based

84 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay (optical density, >/= 0.40) and posi

85 ollected in 211 patients using enzyme-linked immunosorbent assay (Tac/Sir = 104, Tac/Mtx = 107).

86 ingle-molecule (digital) upconversion-linked immunosorbent assay (ULISA) reaches a limit of detection

87 The so-called upconversion-linked immunosorbent assay (ULISA) was critically dependent on

88 bserved with the gold standard enzyme-linked immunosorbent assay - a decrease from 23pg/mL to 0.16pg/

89 ed the cytokine profile (using enzyme-linked immunosorbent assay [ELISA]), reactive oxygen species (R

90 ed by a VZV glycoprotein-based enzyme-linked immunosorbent assay [gpELISA]) and levels of interferon

91 K-1), and beta-catenin; and by enzyme-linked immunosorbent assay analysis of myeloperoxidase (MPO), t

92 iple tissues were estimated by enzyme-linked immunosorbent assay analysis.

93 different platforms, being an enzyme-linked immunosorbent assay and a surface plasmon resonance syst

94 gdorferi (IgG as determined by enzyme-linked immunosorbent assay and confirmed by immunoblot) was per

95 sayed for urinary CXCL10 using enzyme-linked immunosorbent assay and corrected with urinary creatinin

96 or homogenates was measured by enzyme-linked immunosorbent assay and correlated with the uptake of (1

97 o immunization, as assessed by enzyme-linked immunosorbent assay and enzyme-linked immunospot perform

98 now demonstrate by competitive enzyme-linked immunosorbent assay and hydrogen-deuterium exchange mass

99 aling molecules was studied by enzyme-linked immunosorbent assay and immunoblotting.

100 By enzyme-linked immunosorbent assay and immunofluorescence, we found tha

101 dings of 2 orthogonal methods, enzyme-linked immunosorbent assay and mass spectrometry, to validate t

102 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay and serotonin release assay testing

103 dative stress were measured by enzyme-linked immunosorbent assay and spectrophotometrically, respecti

104 evels of MIC1 were measured by enzyme-linked immunosorbent assay and then were categorized into quart

105 in antibodies were measured by enzyme-linked immunosorbent assay and Western blot; AChR, MuSK, and an

106 ood results in the competitive enzyme-linked immunosorbent assay are often unable to provide the requ

107 h a glass chip-based multiplex enzyme-linked immunosorbent assay array and in vitro immunofluorescenc

108 nterleukin-10 were measured by enzyme-linked immunosorbent assay at each time point and compared betw

109 n (IL)-1beta were evaluated by enzyme-linked immunosorbent assay at week 17.

110 ement in relevant pathways and enzyme-linked immunosorbent assay availability.

111 tibody titers were measured by enzyme-linked immunosorbent assay before and after each dose; geometri

112 ergent extracts tested by 82E1 enzyme-linked immunosorbent assay confirmed the presence of bona fide

113 (i) multi-laboratory INNOTEST enzyme linked immunosorbent assay derived cerebrospinal fluid concentr

114 V3-positive cases (12.5%), and enzyme-linked immunosorbent assay detection of anti-PCV3 capsid antibo

115 yclonal antibodies for RDT and enzyme-linked immunosorbent assay development.

116 ity of HPV-16/18 antibodies by enzyme-linked immunosorbent assay for 2D (M0,6) versus 3D (primary), 2

117 thy blood donors was tested by enzyme-linked immunosorbent assay for anti-HCMV immunoglobulin G and i

118 patients with BP underwent an enzyme-linked immunosorbent assay for IgE antibodies against the 16th

119 ted a high correlation with an enzyme-linked immunosorbent assay for sample detection in patients.

120 says, the probe was coupled to an ALP-linked immunosorbent assay for the sensitive and selective dete

121 An IgM antibody-capture enzyme-linked immunosorbent assay for ZIKV was performed on the cerebr

122 GCF was analyzed via enzyme-linked immunosorbent assay for: 1) receptor activator of nuclea

123 y calprotectin was assessed by enzyme-linked immunosorbent assay in 328 subjects including 125 cases

124 of CXCL13 was determined with enzyme-linked immunosorbent assay in all available patients' samples (

125 s were investigated by PCR and enzyme-linked immunosorbent assay in an in vitro diabetes model.

126 analyzed using RT-qPCR and/or enzyme-linked immunosorbent assay in T-cell subsets and PBMCs from pat

127 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay is used to consider immediate treatm

128 pared to a commercial sandwich enzyme-linked immunosorbent assay kit.

129 pared to a commercial sandwich enzyme-linked immunosorbent assay kit.

130 ples were tested by commercial enzyme-linked immunosorbent assay kits for immunoglobulin M/immunoglob

131 levels were analyzed using an enzyme-linked immunosorbent assay method.

132 We performed a cytokine enzyme-linked immunosorbent assay of serum samples from patients with

133 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density greater than or equa

134 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay optical density threshold before ini

135 ous detection techniques (e.g. enzyme-linked immunosorbent assay or ELISA) on solid stationary phase

136 6 levels were assayed using an enzyme linked immunosorbent assay preoperatively, and at 24 and 48 hou

137 Immunoblotting and enzyme-linked immunosorbent assay studies of the patient's serum obtai

138 overy electrochemiluminescence enzyme linked immunosorbent assay technology, and a novel, antibody-in

139 mately 20-fold from the median enzyme-linked immunosorbent assay titers of 30-300 to 3000).

140 ed fluorescence microscopy and enzyme-linked immunosorbent assay to analyze the distribution patterns

141 We used enzyme-linked immunosorbent assay to measure endogenous acyl-ghrelin a

142 , defined by birth anti-PT >30 enzyme-linked immunosorbent assay units (EU)/mL to confer seropositivi

143 ces showed improved binding in enzyme-linked immunosorbent assay using human samples of pediatric lup

144 IKV using IgM antibody-capture enzyme-linked immunosorbent assay was performed in 24 of 40 infants (6

145 Enzyme-linked immunosorbent assay was used to determine levels of thes

146 Enzyme-linked immunosorbent assay was used to measure chemerin and IL-

147 A JCPyV VP1 enzyme-linked immunosorbent assay was used to measure patient and dono

148 ssion, and IgG aCL assessed by enzyme-linked immunosorbent assay were tested as potential predictors.

149 cription-PCR and anti-DENV IgM enzyme-linked immunosorbent assay were used to verify RDT results.

150 nonsurvivors) were analyzed by enzyme-linked immunosorbent assay with clinical data from the US Acute

151 infection sera were assayed by enzyme-linked immunosorbent assay with N-terminal M peptides and bacte

152 action [PCR]) and serological (enzyme-linked immunosorbent assay) analyses were performed on finger-p

153 Plasma peptide YY and ghrelin (enzyme-linked immunosorbent assay) were measured once in 10 fasting vo

154 ts antigenicity (determined by Enzyme-linked Immunosorbent Assay).

155 flammatory cytokine synthesis (enzyme-linked immunosorbent assay).

156 Anti-CMV IgG was measured by enzyme-linked immunosorbent assay, and CMV DNA by polymerase chain rea

157 suPAR was measured by enzyme-linked immunosorbent assay, and events of comorbidity and morta

158 body levels were analyzed with enzyme-linked immunosorbent assay, and frequency of memory B cells, fu

159 n, real-time quantitative PCR, enzyme-linked immunosorbent assay, and immunohistochemical analyses.

160 Gene expression analysis, enzyme-linked immunosorbent assay, and immunohistochemistry consistent

161 ass spectrometry, confirmed by enzyme-linked immunosorbent assay, and localized by confocal microscop

162 by dipstick and albuminuria by enzyme-linked immunosorbent assay, and monocyte depletion had no effec

163 munohistochemical, immunoblot, enzyme-linked immunosorbent assay, and quantitative polymerase chain r

164 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, and serotonin release assay scores.

165 sfatin levels were analyzed by enzyme-linked immunosorbent assay, and the bacterial numbers were eval

166 erminal propeptide (PIIINP) by enzyme-linked immunosorbent assay, and urinary lipoarabinomannan (LAM)

167 nti-GM1 IgM antibody titers in enzyme-linked immunosorbent assay, but not with sera from (disease) co

168 n and then characterized using enzyme-linked immunosorbent assay, flow cytometry, and antiadhesion as

169 nd antibodies were measured by enzyme-linked immunosorbent assay, flow cytometry, or multiplex cytoki

170 Compared to the enzyme-linked immunosorbent assay, our method is label-free and requir

171 lasma mass spectrometry and an enzyme-linked immunosorbent assay, respectively.

172 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay, serotonin release assay, and Warken

173 sphate as a signal reporter in an ALP-linked immunosorbent assay, the proposed system provided compar

174 Using enzyme-linked immunosorbent assay, we analyzed serial sera from the ST

175 Using a newly developed enzyme-linked immunosorbent assay, we evaluated circulating HDGF level

176 Using enzyme-linked immunosorbent assay, we tested M65 and M30 (circulating

177 rotein levels were analyzed by enzyme-linked immunosorbent assay, whereas quantitative PCR was perfor

178 hybrid library was screened by enzyme-linked immunosorbent assay-based kinase inhibition and (33)P Ho

179 were measured with the Wantai enzyme-linked immunosorbent assay.

180 o determine Abeta levels using enzyme-linked immunosorbent assay.

181 on and an IgM antibody-capture enzyme-linked immunosorbent assay.

182 e not elevated by quantitative enzyme-linked immunosorbent assay.

183 analyzed by flow cytometry or enzyme-linked immunosorbent assay.

184 of healthy donors (n = 21) by enzyme-linked immunosorbent assay.

185 cytokine multiplex assays, and enzyme-linked immunosorbent assay.

186 e established a CitH3 specific enzyme-linked immunosorbent assay.

187 ted tomography, histology, and enzyme-linked immunosorbent assay.

188 t of identified antigens using enzyme-linked immunosorbent assay.

189 using a commercially available enzyme-linked immunosorbent assay.

190 were evaluated by fluorometric enzyme-linked immunosorbent assay.

191 10 (IP-10) were quantified by enzyme-linked immunosorbent assay.

192 n of inflammatory mediators by enzyme-linked immunosorbent assay.

193 a, IL1beta, IL1ra, and IL6) by enzyme-linked immunosorbent assay.

194 using a 17-plex Luminex kit or enzyme-linked immunosorbent assay.

195 by a single antibody sandwich enzyme-linked immunosorbent assay.

196 -based immunoglobulin G direct enzyme-linked immunosorbent assay.

197 n L1 virus-like particle-based enzyme-linked immunosorbent assay.

198 r, kidney, and aorta, using an enzyme-linked immunosorbent assay.

199 (IgA) level was measured by an enzyme-linked immunosorbent assay.

200 determined by western blot and enzyme-linked immunosorbent assay.

201 2 in serum from 28 patients by enzyme-linked immunosorbent assay.

202 ometry, 2D-gel analysis and by enzyme-linked immunosorbent assay.

203 -13 levels were measured using enzyme-linked immunosorbent assay.

204 mass spectrometry and sandwich enzyme-linked immunosorbent assay.

205 us proteins were determined by enzyme-linked immunosorbent assay.

206 lutinin (FHA) were assessed by enzyme-linked immunosorbent assay.

207 ng whole-cell and glycoprotein enzyme-linked immunosorbent assay.

208 MR antigens were measured with enzyme-linked immunosorbent assay.

209 ls in serum were measured with enzyme-linked immunosorbent assay.

210 -Psl monoclonal antibody (mAb) enzyme-linked immunosorbent assay.

211 vels of TGM-2 were analyzed by enzyme-linked immunosorbent assay.

212 and lysozyme were analyzed by enzyme-linked immunosorbent assay.

213 a proteome profiler array and enzyme-linked immunosorbent assay.

214 of biomarkers were measured by enzyme-linked immunosorbent assay.

215 terleukin (IL)-1beta levels by enzyme-linked immunosorbent assay.

216 trophic factor was assessed by enzyme-linked immunosorbent assay.

217 e testing for illicit drugs by enzyme-linked immunosorbent assay.

218 ssed in peripheral blood by an enzyme-linked immunosorbent assay.

219 ory cytokines were measured by enzyme-linked immunosorbent assay.

220 nin levels were measured using enzyme-linked immunosorbent assay.

221 metalloproteinase (TIMP)-1 by enzyme-linked immunosorbent assay.

222 obulin (Ig) G dye test and IgM enzyme-linked immunosorbent assay.

223 pecific immunoglobulin G (IgG) enzyme-linked immunosorbent assay.

224 VWF antigen (VWF:Ag) levels by enzyme-linked immunosorbent assay.

225 rotein levels were measured by enzyme-linked immunosorbent assay.

226 mbined with the IgG anti-BP180 enzyme-linked immunosorbent assay.

227 to 18 months, for analysis by enzyme-linked immunosorbent assay.

228 TNF protein levels measured by enzyme-linked immunosorbent assay.

229 -2 complex were assessed using enzyme-linked immunosorbent assay.

230 m Klotho level was measured by enzyme-linked immunosorbent assay.

231 erum levels were determined by enzyme-linked immunosorbent assay.

232 ibody status was determined by enzyme-linked immunosorbent assay.

233 h fluid were measured using an enzyme-linked immunosorbent assay.

234 t reactions were conducted via enzyme-linked immunosorbent assay.

235 n expression was determined by enzyme-linked immunosorbent assay.

236 receptor- 1 was quantified by enzyme-linked immunosorbent assay.

237 in patient synovial fluids by enzyme-linked immunosorbent assay.

238 in 6 (IL-6) were measured with enzyme-linked immunosorbent assay.

239 autoantigens were measured by enzyme-linked immunosorbent assay.

240 with the use of anti-ZIKV IgM enzyme-linked immunosorbent assay.

241 s of analytes were analyzed by enzyme-linked immunosorbent assay.

242 n in Panama and compared to an enzyme-linked immunosorbent assay/Multispot-based testing algorithm.

243 m levels were determined using enzyme-linked immunosorbent assay: 1) IL-1beta; 2) IL-6; 3) IL-17A; 4)

244 antiplatelet factor 4/heparin enzyme-linked immunosorbent assay; 10 patients were identified as hepa

245 2 using a Meso Scale Discovery enzyme linked immunosorbent assay; and (iii) cerebrospinal fluid amylo

246 ect pathogens in plant include enzyme-linked immunosorbent assays (ELISA) and direct tissue blot immu

247 weakness inherent to multiplex enzyme-linked immunosorbent assays (ELISA) is generation of false sign

248 r's disease were quantified by enzyme-linked immunosorbent assays (ELISA) or theoretically calculated

249 ed demographic information and enzyme-linked immunosorbent assays (ELISA) which tested serological HB

250 G antibodies in the subsequent enzyme-linked immunosorbent assays (ELISA), and yielded 18-35% total i

251 us existing techniques such as enzyme-linked immunosorbent assays (ELISA), Western blot, high perform

252 nd Lb6H, and evaluated both in enzyme-linked immunosorbent assays (ELISA).

253 d using commercially available enzyme-linked immunosorbent assays (ELISA).

254 trometry (LB-MS) in support of enzyme-linked immunosorbent assays (ELISA).

255 n detection methods, including enzyme-linked immunosorbent assays (ELISAs) and dip-stick methods, do

256 Combined with enzyme-linked immunosorbent assays (ELISAs) and fluorescence-activated

257 Enzyme-linked immunosorbent assays (ELISAs) based on ZIKV and DENV non

258 The different enzyme-linked immunosorbent assays (ELISAs) for gluten detection each

259 more sensitive than classical enzyme-linked immunosorbent assays (ELISAs) in the quantification of H

260 Competition enzyme-linked immunosorbent assays (ELISAs) showed that antisera from

261 time for diagnosis, four rapid enzyme-linked immunosorbent assays (ELISAs) were developed using two p

262 ion of DENV serotypes 1-4, and enzyme-linked immunosorbent assays (ELISAs), for detection of DENV non

263 iplate96 well plate for use in enzyme-linked immunosorbent assays (ELISAs).

264 id tests, IgM antibody capture enzyme-linked immunosorbent assays (MAC-ELISAs), and indirect immunofl

265 Peptides were tested in enzyme-linked immunosorbent assays against celiac disease patients' se

266 testing for these diseases by enzyme-linked immunosorbent assays and dissection of various pathophys

267 us, and chikungunya virus; IgM enzyme-linked immunosorbent assays and plaque-reduction neutralization

268 at baseline using quantitative enzyme-linked immunosorbent assays and used to stratify patients into

269 CAM-1]) were measured by using enzyme-linked immunosorbent assays at 1 day, 2 weeks, and 5 weeks afte

270 ha levels were estimated using enzyme-linked immunosorbent assays in GCF and serum samples collected

271 te in 489 coke-oven workers by enzyme-linked immunosorbent assays in validation stage.

272 parin-induced thrombocytopenia enzyme-linked immunosorbent assays optical density; had a higher preva

273 of mothers were measured using enzyme-linked immunosorbent assays or a microneutralization test.

274 ws great promise toward use in enzyme-linked immunosorbent assays or other analytical techniques wher

275 le inhibitory effects in model enzyme-linked immunosorbent assays or polymerase chain reactions, indi

276 munoassay determined LTB4, and enzyme-linked immunosorbent assays quantified tumor necrosis factor (T

277 d on biosensor experiments and enzyme-linked immunosorbent assays shows that the DnaB-DnaC complex bi

278 analyzed histologically or by enzyme-linked immunosorbent assays to measure cytokine levels; T cells

279 Comparative enzyme-linked immunosorbent assays with monoclonal antibodies against

280 unoblot, immunohistochemistry, enzyme-linked immunosorbent assays, and metabolite assays; cells and t

281 sed for Ab responses to AM via enzyme-linked immunosorbent assays, and to AM OS epitopes via novel gl

282 protein levels by Luminex and enzyme-linked immunosorbent assays, respectively.

283 Because ALP is widely used in enzyme-linked immunosorbent assays, the probe was coupled to an ALP-li

284 fluorescent assays [IFA] and 2 enzyme-linked immunosorbent assays-both HHV8 lytic and latent antigen

285 hen-induced liver injury using enzyme-linked immunosorbent assays.

286 erum by immunofluorometric and enzyme-linked immunosorbent assays.

287 and MMP-8 were measured using enzyme-linked immunosorbent assays.

288 edical diagnostics, such as in enzyme-linked immunosorbent assays.

289 receptor antagonist (ra) using enzyme-linked immunosorbent assays.

290 y qualitative and quantitative enzyme-linked immunosorbent assays.

291 y levels were assessed using 2 enzyme-linked immunosorbent assays.

292 evel via proteome profiler and enzyme-linked immunosorbent assays.

293 ped flow cytometric and T cell enzyme-linked immunosorbent spot (ELISpot) approaches to characterize

294 interleukin-4 (IL-4) T-helper enzyme-linked immunosorbent spot (ELISpot) assays of the CD4bs-occlude

295 f interferon gamma production (enzyme-linked immunosorbent spot [ELISPOT] assays) by splenocytes from

296 est (kSORT), and the IFN-gamma enzyme-linked immunosorbent spot assay (ELISPOT) assay were assessed i

297 using the Quantiferon-CMV, an enzyme-linked immunosorbent spot assay (ELISpot), and intracellular cy

298 sed them in a gamma interferon enzyme-linked immunosorbent spot assay to interrogate CD8(+) and CD4(+

299 ed guinea pig gamma interferon enzyme-linked immunosorbent spot assay.

300 ntified using interferon gamma enzyme-linked immunosorbent spot assays.